Jeil Pharmaceutical Co.,Ltd (271980.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩8,800 (-1.01%) as of
Key statistics
- Market cap
- 129.40B
- Dividend yield
- 0.00%
- 52-week range
- 8,720.00 – 19,290.00
- Beta
- 0.60
- Revenue (TTM)
- 543.49B
- Profit margin
- 1.71%
- Volume
- 10.00k
About Jeil Pharmaceutical Co.,Ltd
Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea and internationally. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company exports its products. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 1,024
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.